APA (7th ed.) Citation

Builes-Montaño, C. E., Suarez-Rodriguez, A. F., & Alzate-Vinasco, M. A. (2026). Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis. Diabetes Therapy, 17(7), 1067. https://doi.org/10.1007/s13300-026-01886-0

Chicago Style (17th ed.) Citation

Builes-Montaño, Carlos E., Andres F. Suarez-Rodriguez, and Maria A. Alzate-Vinasco. "Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis." Diabetes Therapy 17, no. 7 (2026): 1067. https://doi.org/10.1007/s13300-026-01886-0.

MLA (9th ed.) Citation

Builes-Montaño, Carlos E., et al. "Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis." Diabetes Therapy, vol. 17, no. 7, 2026, p. 1067, https://doi.org/10.1007/s13300-026-01886-0.